Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2

NCT03278483 is registered in ClinicalTrials.gov with Instituto Nacional de Salud Publica, Mexico as lead sponsor.

NCT NCT03278483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2
Lead sponsor
Instituto Nacional de Salud Publica, Mexico
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2019
Completion date
February 28, 2019
Enrollment
396 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, tuberculin (skin test) positive